American pharma giant Pfizer ($PFE) leads the pack as pharmaceutical companies plan price increases for at least 350 branded ...

Pfizer recently announced its guidance for 2026. One thing seems clear: Its financial results won't get much stronger. It ...

More than a dozen pharmas have recently struck deals with the White House to lower drug prices. Nevertheless, drugmakers ...

LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to ...

TrumpRx is supposed to launch in early 2026. Here's what we know about how buying medicine through the site to get discounts ...

While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the ...

Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson (NYSE:JNJ) executive, as the company’s new chief internal medicine officer to boost the company's efforts in obesity drug development ...

(Gray News) - The White House unveiled a direct-to-consumer website for Americans to buy medication, called “TrumpRx.” The White House also announced a deal with Pfizer to lower the prices of its ...

America’s healthcare system has gone through significant change in recent years. Many creative ideas on how to improve America’s healthcare system are being tried at the local, state and federal level ...